Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.27B |
| 2 |
Microsoft
MSFT
|
+$452M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
+$427M |
| 4 |
RTX Corp
RTX
|
+$341M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$333M |
Top Sells
| 1 |
AABA
Altaba Inc. Common Stock
AABA
|
+$268M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$128M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| 1 | Technology | 13.84% |
| 2 | Financials | 11.67% |
| 3 | Healthcare | 11.33% |
| 4 | Consumer Discretionary | 10.16% |
| 5 | Communication Services | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBD
2026
DELISTED
Diebold Nixdorf Incorporated
DBD
| $508K | ﹤0.01% |
31,074
+28,324
| +1,030% | +$463K |
|
2027
ACI Worldwide
ACIW
$5.18B
| $506K | ﹤0.01% |
22,330
+12,977
| +139% | +$294K |
|
2028
FerroAtlántica
GSM
$773M
| $506K | ﹤0.01% |
31,229
-17,264
| -36% | -$280K |
|
|
CADE
2029
DELISTED
Cadence Bancorporation
CADE
| $505K | ﹤0.01% |
18,633
+13,624
| +272% | +$369K |
|
2030
Ichor Holdings
ICHR
$579M
| $504K | ﹤0.01% |
20,469
+14,611
| +249% | +$360K |
|
2031
Franco-Nevada
FNV
$38.6B
| $503K | ﹤0.01% |
6,296
-2,016
| -24% | -$161K |
|
2032
iShares Currency Hedged MSCI Emerging Markets
HEEM
$182M
| $503K | ﹤0.01% |
+18,996
| New | +$503K |
|
|
PPBI
2033
DELISTED
Pacific Premier Bancorp
PPBI
| $503K | ﹤0.01% |
12,557
-2,668
| -18% | -$107K |
|
2034
Editas Medicine
EDIT
$242M
| $502K | ﹤0.01% |
16,313
+3,510
| +27% | +$108K |
|
2035
NovoCure
NVCR
$1.36B
| $502K | ﹤0.01% |
24,840
+13,512
| +119% | +$273K |
|
2036
Johnson Outdoors
JOUT
$422M
| $501K | ﹤0.01% |
8,070
+2,700
| +50% | +$168K |
|
2037
VirnetX
VHC
$74.7M
| $501K | ﹤0.01% |
6,768
+3,537
| +109% | +$262K |
|
2038
Kelly Services Class A
KELYA
$481M
| $500K | ﹤0.01% |
18,337
+17,630
| +2,494% | +$481K |
|
|
MLNT
2039
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $498K | ﹤0.01% |
+6,302
| New | +$498K |
|
|
VR
2040
DELISTED
Validus Hold Ltd
VR
| $498K | ﹤0.01% |
10,617
-56,254
| -84% | -$2.64M |
|
2041
Vanguard Information Technology ETF
VGT
$103B
| $494K | ﹤0.01% |
3,000
| – | – |
|
2042
Glacier Bancorp
GBCI
$5.8B
| $492K | ﹤0.01% |
12,494
+504
| +4% | +$19.8K |
|
|
CSFL
2043
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $492K | ﹤0.01% |
19,108
+14,689
| +332% | +$378K |
|
|
LHCG
2044
DELISTED
LHC Group LLC
LHCG
| $491K | ﹤0.01% |
7,993
-4,105
| -34% | -$252K |
|
|
MDCO
2045
DELISTED
Medicines Co
MDCO
| $491K | ﹤0.01% |
17,971
-9,504
| -35% | -$260K |
|
|
TOWR
2046
DELISTED
Tower International, Inc.
TOWR
| $491K | ﹤0.01% |
16,067
+9,210
| +134% | +$281K |
|
|
FNGN
2047
DELISTED
Financial Engines, Inc.
FNGN
| $487K | ﹤0.01% |
16,077
-24,704
| -61% | -$748K |
|
2048
Lands' End
LE
$475M
| $485K | ﹤0.01% |
24,787
+11,521
| +87% | +$225K |
|
|
LOXO
2049
DELISTED
Loxo Oncology, Inc
LOXO
| $485K | ﹤0.01% |
5,773
+3,108
| +117% | +$261K |
|
2050
Integra LifeSciences
IART
$1.17B
| $483K | ﹤0.01% |
10,093
-10,698
| -51% | -$512K |
|